RxDoctor Payments DataLook up a doctor →

Jodi Strock, NP

Nurse Practitioner · Auburn, INNPI 1417236530

Payments from drug & device makers

$19,128in general payments, 2019–2025

Across 602 payments — averaging $31.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Novo Nordisk$2K
  • AstraZeneca$2K
  • Amgen$2K
  • Lilly USA, LLC$1K
  • GSK$1K
  • plus $8K from 45 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie149$3,479
Novo Nordisk64$1,836
AstraZeneca(2 entities)46$1,798
Amgen46$1,504
Lilly USA, LLC57$1,397
GSK45$1,357
Axsome Therapeutics, Inc.27$976
Johnson & Johnson(2 entities)10$835
Pharmacosmos Therapeutics Inc.4$465
Pfizer22$432
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)16$314
Emmaus Medical, Inc.2$311
Incyte Corporation3$306
Biohaven Pharmaceutical Holding Company Ltd.4$291
Astellas Pharma US Inc9$275
Taiho Oncology, Inc.2$228
Exact Sciences13$222
Daiichi Sankyo Inc.2$218
Lundbeck LLC10$208
Otsuka America Pharmaceutical, Inc.5$176
Boehringer Ingelheim9$154
Phathom Pharmaceuticals, Inc.3$152
Sobi, Inc1$125
Dova Pharmaceuticals1$125
Gilead1$124
Pharmacyclics LLC, An Abbvie Company1$122
Acrotech Biopharma Inc.1$120
Karyopharm Therapeutics Inc.2$119
E.r. Squibb & Sons, L.L.C.1$115
Rigel Pharmaceuticals, Inc.1$110
Epizyme, Inc.1$100
Therapeuticsmd, Inc.1$100
Dynavax Technologies Corporation3$93
Alnylam Pharmaceuticals Inc.4$90
Beigene USA, Inc.1$88
Biohaven Pharmaceuticals, Inc.1$85
TG Therapeutics, Inc.1$83
Takeda Pharmaceuticals U.S.A., Inc.5$79
Abbott4$73
Sunovion Pharmaceuticals Inc.3$68
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC4$65
Bayer3$62
Nestle Healthcare Nutrition Inc.3$51
Sumitomo Pharma America, Inc.2$42
Xeris Pharmaceuticals, Inc.2$38
Radius Health, Inc.2$36
Corcept Therapeutics1$22
Supernus Pharmaceuticals, Inc.1$21
Dexcom, Inc.1$18
Amarin Pharma, Inc.1$14
Corium, LLC1$6

How this compares

$19,128 in reported general payments places this provider in the 95th percentile of 2,724 nurse practitioner providers in Indiana.

See all nurse practitioner providers in Indiana →

Medicare billing

Part B allowed, 2024
$20,772
Medicare patients
71
Services billed
400

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Auburn

See the full list for Indiana →

Where these figures come from

Is this you, or does something look wrong? →